
Torplat 90 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Ticagrelor (90mg)
Overview Torplat 90 Tablet
CardioGuard 90mg tablets are antiplatelet agents, working to inhibit the formation of potentially dangerous blood clots within blood vessels. This action helps prevent cardiac events such as strokes and heart attacks, particularly in individuals with pre-existing heart conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack or experiencing severe angina pectoris, especially following cardiac stent placement. Its use aids in preventing further cardiovascular complications, including recurrent heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet medication, will typically be prescribed by your physician. CardioGuard 90mg can be administered with or without food, consistently at the same time daily for optimal efficacy. Discontinuing treatment increases the risk of future cardiovascular incidents; consistent use is crucial even during periods of well-being. Increased bleeding risk is the most frequent side effect. Minor cuts and injuries may bleed longer than usual, though this typically resolves spontaneously. Mild dyspnea (shortness of breath) may occur, usually subsiding with continued therapy. Report persistent bleeding, worsening, or persistent shortness of breath to your physician. CardioGuard 90mg is contraindicated in individuals with active internal bleeding (e.g., gastric ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to commencing treatment.
Uses of Torplat 90 Tablet
Averting cardiac arrest and cerebrovascular events
Major Benefits of Torplat 90 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Torplat 90 Tablet. Swallow the tablet whole; do not chew, crush, or divide it. While Torplat 90 Tablet can be taken with or without food, consistent timing is recommended.
Common Side effects of Torplat 90 Tablet:
- Bleeding
- Breathlessness
How to use Torplat 90 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Torplat 90 Tablet can be taken with or without food, although consistent timing is recommended.
How Torplat 90 Tablet works:
Aggrenox 90mg tablets are antithrombotic agents. Their mechanism of action inhibits platelet aggregation, reducing the risk of dangerous blood clots and consequently lowering the likelihood of cardiovascular events such as myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Torplat 90 Tablet necessitates caution. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Torplat 90 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Lactation-related data for Torplat 90 Tablet is currently unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Torplat 90 Tablet.
KidneySAFE IF PRESCRIBED
Torplat 90 Tablet poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Data regarding Torplat 90 Tablet use in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Torplat 90 Tablet cautiously, potentially requiring dosage modification under medical supervision. Torplat 90 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Torplat 90 Tablet :
Should you forget a Torplat 90 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Torplat 90 Tablet
Label | Value |
---|---|
Chemical Type | Triazolopyrimidine derivatives |
Developing Habits | No. |
Treatment Category | KINSHIP |
Action Class | ADP receptor antagonists (P2Y12 inhibitors) |